{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:28:29Z","timestamp":1772058509896,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.eururo.2008.06.062","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:01:19Z","timestamp":1214456479000},"page":"971-973","source":"Crossref","is-referenced-by-count":49,"title":["Is Maintenance Bacillus Calmette-Gu\u00e9rin Really Necessary?"],"prefix":"10.1016","volume":"54","author":[{"given":"Harry W.","family":"Herr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2008.06.062_bib1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance BCG immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical BCG reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","article-title":"Intravesical BCG versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression","volume":"63","author":"Bohle","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.06.062_bib5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1987.5.3.441","article-title":"A prospective randomized trial of maintenance versus nonmaintenance intravesical BCG therapy of superficial bladder cancer","volume":"5","author":"Badalament","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2008.06.062_bib6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0022-5347(05)66333-1","article-title":"Control group and maintenance treatment with BCG for carcinoma in situ and\/or high grade bladder tumors","volume":"165","author":"Palou","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-5347(17)43125-9","article-title":"Single course versus maintenance BCG therapy for superficial bladder tumors: a prospective randomized trial","volume":"138","author":"Hudson","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib8","first-page":"1459","article-title":"Comparative study on prophylactic intravesical instillation of BCG and adriamycin for superficial bladder cancers","volume":"80","author":"Tachibana","year":"1989","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.eururo.2008.06.062_bib9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H","article-title":"BCG treatment of existing papillary bladder cancer and carcinoma in situ of the bladder","volume":"75","author":"Akaza","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2008.06.062_bib10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1191\/1740774505cn087oa","article-title":"Meta-analysis of individual patient data from randomized trials: a review of methods used in practice","volume":"2","author":"Simmonds","year":"2005","journal-title":"Clinical Trials"},{"key":"10.1016\/j.eururo.2008.06.062_bib11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0895-4356(94)00112-4","article-title":"Cumulative meta analysis of clinical trials builds evidence for exemplary medical care: discussion","volume":"48","author":"Cook","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eururo.2008.06.062_bib12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib13","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0022-5347(01)62377-2","article-title":"Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and BCG versus mitomycin C alone in patients with superficial bladder cancer","volume":"160","author":"Witjes","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomized study of intravesical mitomycin C Tice and BCG RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"Vegt","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0090-4295(98)00212-X","article-title":"Long-term follow-up of an EORTC randomized prospective trial comparing intravesical BCG-RIVM and mitomycin C in superficial bladder cancer","volume":"52","author":"Witjes","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.06.062_bib16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"BCG therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2008.06.062_bib17","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.06.062_bib18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1464-410X.2003.04764.x","article-title":"BCG therapy in stage Ta\/T1 bladder cancer: progression factors for time to recurrence and progression","volume":"93","author":"Andius","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.06.062_bib19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with BCG therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808007689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808007689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T06:09:54Z","timestamp":1557641394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808007689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0302283808007689"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.06.062","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}